The Role of Helicobacter pylori in Pathogenesis: the Spectrum of Clinical Outcomes

References

• Marshall B J. Epidemiology of H. pylori in Western Countries. Helicobacter pylori: basic mechanisms to clinical cure, R H Hunt, G NJ Tytgat. Kluwer, Lancaster 1994; 75–84
   Google Scholar
• Hazell S L. H. pylori in developing countries. Helicobacter pylori: basic mechanisms to clinical cure, R H Hunt, G NJ Tytgat. Kluwer, Lancaster 1994; 85–94
   Google Scholar
• Mendall M A, Pajares-Garcia J. Epidemiology and transmission of Helicobacter pylori. Curr Opin Gastroenterol 1995; 11 Suppl: 1–4
   Web of Science ®Google Scholar
• Jackson C J, Kelly D J, Clayton C L. The cloning and characterization of chemotaxis genes in Helicobacter pylori. Abstracts of the 8th International Workshop on Campylobacters, Helicobacters and Related Organisms, WinchesterEngland, 1995, 65
   Google Scholar
• Berstad K, Sjødahl R, Berstad A. Phospholipase A2 activity in gastric juice in patients with active and H. pylori eradicated healed duodenal ulcer. Aliment Pharmacol Ther 1994; 8: 175–80
   PubMed Web of Science ®Google Scholar
• Mobley H LT. Defining Helicobacter pylori as a pathogen: strain heterogeneity and virulence. Am J Med 1996; 100(SA): 2S–9S
   Google Scholar
• Eaton K A, Brooks C L, Morgan C R, Krakowka S. Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets. Infect Immun 1991; 59: 2470–5
   PubMed Web of Science ®Google Scholar
• Leunk R D, Johnson P T, David B C, et al. Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J Med Microbiol 1988; 26: 93–9
   PubMed Web of Science ®Google Scholar
• Telford J L, Ghiara P, Dell'Orco M, Comanducci M, Burroni D, Bugnoli M, et al. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J Exp Med 1994; 179: 1653–8
   PubMed Web of Science ®Google Scholar
• Cover T L, Dooley C P, Blaser M J. Characterization of human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun 1990; 58: 603–10
   PubMed Web of Science ®Google Scholar
• Atherton J C, Cao P, Peek R M, Jr, et al. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995; 270: 1771–7
   Web of Science ®Google Scholar
• Kuipers E J, Uyterlinde A M, Nelis G F, et al. Long-term sequelae of Helicobacter pylori-associated gastritis. Lancet 1995; 345: 1525–8
   PubMed Web of Science ®Google Scholar
• Kuipers E J, Perez-Perez G I, Meuwissen S GM, Blaser M J. Infection with cagA Positive Helicobacter pylori strains increases the risk for atrophic gastritis. Gastroenterol 1995; 108(4)A137
   Google Scholar
• Crabtree J E, Taylor J D, Wyatt J I, et al. Mucosal IgA recognition of Helicobacter pylori 120kDa protein, peptic ulceration and gastric pathology. Lancet 1991; 338: 332–5
   PubMed Web of Science ®Google Scholar
• Lange N, Censino S, Xiang Z, et al. The cagl chromosomal region of Helicobacter pylori is type I-specific and encodes exporter molecules and invasion genes. Abstracts of the 8th International Workshop on Campylobacters, Helicobacters and Related Organisms, WinchesterEngland, 1995, 63
   Google Scholar
• Tummuru M KR, Sharma S A, Blaser M J. Helicobacter pylori picB, a homologue of the Bordetella pertussis secretion protein, is required for induction of IL-8 in gastric epithelial cells. Mol Microbiol 1995; 18: 867–76
   PubMed Web of Science ®Google Scholar
• Akopyants N S, Kersulyte D, Berg D E. Cagll, a new multigene locus associated with virulence in Helicobacter pylori. Gut 1995; 37 Suppl 1: A1
   Google Scholar
• Knapp S, Hacker J, Jarchau T, Goebel W. Large, unstable inserts in the chromosome affect virulence properties of uropathogenic Escherichia coli 06 strain 536. J Bacteriol 1986; 168: 22–30
   PubMed Web of Science ®Google Scholar
• Azuma T, Konishi J, Yanaka Y, Hirai M, Ito S, Kato T, Kohli Y. Contribution of HLA-DQA gene to host's response against Helicobacter pylori (Letter). Lancet 1994; 343: 542–3
   PubMed Web of Science ®Google Scholar
• Azuma T, Ito Y, Miyaji H, Konishi J, Tanaka Y, Ito S, et al. Host's genetic difference between Helicobacter pylori-positive and Helicobacter pylori-negative gastric carcinoma [Abstract]. Gastroenterology 1995; 108(4), AGA.
   Web of Science ®Google Scholar
• Steer H W. Ultrastructure of Campylobacter pylori in vivo. Campylobacter pylori and gastroduodenal disease, B J Rathbone, R Heatley. Blackwell Scientific, Oxford 1989; 189
   Google Scholar
• Boren T, Falk P, Roth K A, et al. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 1993; 262: 1892–5
   PubMed Web of Science ®Google Scholar
• Deusch K, Seifarth C, Reich K, Classen M. T cell subsets in H. pylori associated gastritis. Helicobacter pylori: basic mechanisms to clinical cure, R H Hunt, G NJ Tytgat. Kluwer, London 1994; 321–32
   Google Scholar
• Crowe S E, Alvarez L, Dytoc M, Hunt R H, Muller M, Sherman P, et al. Expression of interleukin 8 and CD54 by human gastric epithelium after Helicobacter pylori infection in vitro. Gastroenterology 1995; 108(1)65–74
   PubMed Web of Science ®Google Scholar
• Crabtree J E, Farmery S M, Lindley I JD, Figura N, Peichl P, Tompkins D S. CagA cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines. J Clin Pathol 1994; 47: 945–50
   PubMed Web of Science ®Google Scholar
• Crabtree J E, Covacci A, Farmery S M, Xiang Z, Tompkins D S, Perry S, et al. Helicobacter pylori induces interleukin-8 expression in gastric epithelial cells in association with CagA positive phenotype. J Clin Pathol 1995; 48: 41–5
   PubMed Web of Science ®Google Scholar
• Mai U EH, Perez-Perez G I, Allen J B, Wahl S M, Blaser M J, Smith P D. Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa. J Exp Med 1992; 175: 517–25
   PubMed Web of Science ®Google Scholar
• Rautelin H, Blomberg B, Fredlund H, Jarnerot G, Danielsson D. Incidence of Helicobacter pylori strains activation neutrophils in patients with peptic ulcer disease. Gut 1993; 34: 599–603
   PubMed Web of Science ®Google Scholar
• Crabtree J E, Shallcross T M, Heatley R V, Wyatt J I. Mucosal tumor necrosis factor alpha, and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut 1993; 32: 1473–7
   Web of Science ®Google Scholar
• Fan X J, Chua A, O'Connell M A, et al. Interferon-gamma and tumor necrosis factor production in patients with Helicobacter pylori infection. Irish J Med Sci 1993; 162: 408–11
   PubMed Web of Science ®Google Scholar
• Denizot Y, Sobhani I, Rambaud J C, et al. Paf-acether synthesis by Helicobacter pylori. Gut 1990; 31: 1242–5
   PubMed Web of Science ®Google Scholar
• Muller M J, Hunt R H. Inflammation, acid and ulcers. Yale J Biol Med 1994; 67: 135–44
   PubMed Web of Science ®Google Scholar
• Calam J. Pathogenic mechanisms. Helicobacter pylori. Baillière's Clin Gastroenterol, J Calam, 1995; 9(3): 487–506
   Google Scholar
• Gledhill T, Leicester R J, Addis B, Lightfoot N, Barnard J, Viney N, et al. Epidemic hypochlorhydria. Br Med J 1985; 290: 1383–6
   PubMed Web of Science ®Google Scholar
• Hunt R H. Epidemic Hypochlorhydria. Helicobacter (Campylobacter) pylori and gastroduodenal disease, Second Ed., B Rathbone, R V Heatley. Blackwell, Oxford, 187–97
   Google Scholar
• Rangachari P K. Helicobacter pylori and hypergastrinaemia: the Quisling option. Scand J Gastroenterol 1991; 187 Suppl 26: 85–90
   Web of Science ®Google Scholar
• Graham D Y, Opekum A, Lew G M. Ablation of exaggerated meal-stimulated gastrin release in duodenal ulcer patients after clearance of Helicobacter (Campylobacter) pylori infection. Am J Gastroenterol 1990; 85: 394–8
   PubMed Web of Science ®Google Scholar
• Prewett E J, Smith J FL, Nivokolo C U, Hudson M, Sawyerr A M, Pounder R E. Eradication of Helicobacter pylori associated 24 hour hypergastrinaemia: a prospective study in healthy subjects. Aliment Pharmacol Ther 1991; 5: 283–90
   PubMed Web of Science ®Google Scholar
• Murthy U K, Linscheer R, Cho C. The hypergastrinaemia in Helicobacter pylori gastritis due to a decrease in antral D cell density and D:G cell ratio. Gastroenterology 1992; A130
   Google Scholar
• Haruma K, Sumii K, Okamoto S, Yoshiraha M, Tari A, et al. Helicobacter pylori causes low antral somatostatin content: pathogenesis of inappropriate hypergastrinaemia. Gastroenterology 1992; A80
   Google Scholar
• Queiroz D M, Moura S B, Mendes E N, Rocha G A. Effect of Helicobacter pylori eradication on antral gastrin, somatostatin immunoreactive cell density and gastrin and somatostatin concentration. Scand J Gastroenterol 1993; 28(10)858–64
   PubMed Web of Science ®Google Scholar
• McColl K EL, El-Omar E. Effect of H. pylori infection on gastrin and gastric acid secretion. Helicobacter pylori: basic mechanisms to clinical cure, R H Hunt, G NJ Tytgat. Kluwer, Lancaster 1994; 245–56
   Google Scholar
• El-Omar E M, Penman I D, Ardill J E, Chittajallu R S, et al. Helicobacter pylori infection and abnormatlities of acid secretion in patients with duodenal ulcer disease. Gastroenterol 1995; 109(3)681–91
   PubMed Web of Science ®Google Scholar
• Jacobson K, Chiba N, James C, Armstrong D, Barrientos M, Hunt R H. Protracted gastric acid secretion in H. pylori positive DU patients following eradication. Gastroenterology 1995; 108(4)A122
   Web of Science ®Google Scholar
• Wyatt J I, Rathbone B J. Immune response of the gastric mucosa to Campylobacter pylori. Scand J Gastroenterol 1988; 23 Suppl 142: 44–9
   Web of Science ®Google Scholar
• Harris A W, Walker M M, Baron J H, Misiewicz J J. Gastric metaplasia in the duodenal bulb before and six months after eradication of Helicobacter pylori. Gastroenterology 1995; 108(4)A108
   PubMedGoogle Scholar
• Rademaker J W, Hunt R H. H. pylori and gastric acid secretion: the ulcer link?. Scand J Gastroenterol 1991; 187 Suppl 26: 71–7
   Web of Science ®Google Scholar
• Sipponen P, Seppala K, Aarynen M, Helske T, Kettunen P. Chronic gastritis and gastroduodenal ulcer. Gut 1989; 30: 922–9
   PubMed Web of Science ®Google Scholar
• Sipponen P. Helicobacter pylori: a cohort phenomenon. Am J Gastroenterol 1995; 19 Suppl 1: S30–36
   Google Scholar
• Carrick J, Lee A, Hazell S, Ralston M, Daskaloponlos G. Campylobacter pylori, duodenal ulcer and gastric metaplasia: possible role of functional heterotopic tissue in neurogenesis. Gut 1989; 30: 790–2
   PubMed Web of Science ®Google Scholar
• Rauws E, Tytgat G NJ. Eradication of Helicobacter pylori cures duodenal ulcer. Lancet 1990; 1: 1233
   Web of Science ®Google Scholar
• Mohamed A H, Wilkinson J, Hunt R H. Duodenal ulcer recurrence after Helicobacter pylori (Hp) eradication: a meta-analysis. Gastroenterology 1994; 106(4)A142
   Google Scholar
• Freston J W. H2-receptor antagonists and duodenal ulcer recurrence: analysis on efficacy and commentary on safety, costs and patient selection. Am J Gastroenterol 1987; 82: 1242–9
   PubMed Web of Science ®Google Scholar
• Beales J LP, Davey N, Scunes D, Pusey C, Lechler R, Calam J. HLA class II type and H. pylori induced gastric atrophy. Gut 1994; 35 Suppl 5: S45
   Google Scholar
• Li Y Y, Hu P J, Liu D Q, Lin H L, Chen M H, Hazell S L, et al. Helicobacter pylori and gastric cancer: an endoscopic survey of healthy children in high and low risk areas for gastric cancer in China
   Google Scholar
• Sobala G M, Schorah C J, Shires S, et al. Effect of eradication of Helicobacter pylori on gastric juice ascorbic acid concentrations. Gut 1993; 34: 1038–41
   PubMed Web of Science ®Google Scholar
• Zhang S W, Patchett S E, Perrett D, Wilks M, Lin L, Domizio P, et al. CagA Seropositivity is associated with reduced Gastric Juice Vitamin C Concentrations. Gastroenterology 1995; 108(4)A267
   Web of Science ®Google Scholar
• International Agency for Research on Cancer. Schistosomes, liver flukes and Helicobacter pylori. IARC, Lyon 1994; 61: 177–241
   Google Scholar
• Forman D, Webb P M. H. pylori and gastric cancer: the significance of the problem. Helicobacter pylori: basic mechanisms to clinical cure, R H Hunt, G NJ Tytgat. Kluwer, Lancaster 1994; 461–8
   Google Scholar
• Lechago J, Correa P. Prolonged achlorhydria and gastric neoplasia: Is there a causal relationship?. Gastroenterology 1993; 104(8)1554–6
   PubMedGoogle Scholar
• Lundergardh G, Ekbom A, McLaughlin J K, Nyren O. The cancer risk after vagotomy. Gut 1994; 35: 946–9
   PubMed Web of Science ®Google Scholar
• McCloy R F, Arnold R, Bardhan K D, Cattan D, Klinkenberg-Knol E, Maton P N, et al. Pathophysiological effects of long-term acid suppression in man. Dig Dis Sci 1995; 40(2)96S–120S
   PubMed Web of Science ®Google Scholar
• Cahill R J, Sant S, Beattie S, Hamilton H, O'Morain C. Helicobacter pylori and increased epithelial cell proliferation: a risk factor for cancer. Eur J Gastroenterol Hepatol 1994; 6: 1123–7
   Web of Science ®Google Scholar
• Cahill R J, Xia H, Kilgallen C, Beattie S. Effect of eradication of Helicobacter pylori infection on gastric epithelial cell proliferation. Dig Dis Sci 1995; 40(8)4–8
   Web of Science ®Google Scholar
• Blaser M J, Parsonnet J. Parasitism by the 'slow' bacteria Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J Clin Invest 1994; 94: 4–8
   PubMed Web of Science ®Google Scholar
• Eidt S, Stolte M, Fischer R. Helicobacter pylori gastritis and primary gastric non-Hodgkin's lymphomas. J Clin Pathol 1994; 47: 436–9
   PubMed Web of Science ®Google Scholar
• Parsonnet J, Hansens, Rodriguez L, Gelb A B. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994; 330(18)1267–71
   PubMed Web of Science ®Google Scholar
• Zaki M, Schubert M L. Helicobacter pylori and gastric lymphoma. Gastroenterology 1995; 108(2)610–2
   PubMedGoogle Scholar
• Greiner A, Marx A, Heesemann J, Schmausser B, Muller-Hermelink H K. Idiotype identity in a MALT-type lymphoma and B cells in Helicobacter pylori associated chronic gastritis. Lab Invest 1994; 70: 572–8
   PubMed Web of Science ®Google Scholar